TMTA Transmeta (MM)

Transmeta Corporation (NASDAQ:TMTA) today announced that its Board of Directors has scheduled its Annual Meeting of Stockholders for Thursday, September 18, 2008. The meeting will be held at the Hilton Santa Clara Hotel located at 4949 Great America Parkway, Santa Clara, California, starting at 8 a.m. Pacific Daylight Time. Stockholders of record at the close of business on August 19, 2008 will be entitled to vote at the Annual Meeting. Notice of the Annual Meeting and related proxy materials will be mailed to all stockholders of record on or about August 25, 2008. Any additional proposals of stockholders to be considered for presentation at the Annual Meeting must be presented in writing and received by Transmeta�s Secretary at Transmeta's corporate office no later than the close of business on August 15, 2008. About Transmeta Corporation Transmeta Corporation develops and licenses innovative computing, microprocessor and semiconductor technologies and related intellectual property. Founded in 1995, we first became known for designing, developing and selling our highly efficient x86-compatible software-based microprocessors, which deliver a balance of low power consumption, high performance, low cost and small size suited for diverse computing platforms. We are presently focused on developing and licensing our advanced power management technologies for controlling leakage and increasing power efficiency in semiconductor and computing devices, and in licensing our computing and microprocessor technologies to other companies. To learn more about Transmeta, visit www.transmeta.com. Safe Harbor Statement This release contains forward-looking statements made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Such statements speak only as of the date of this release, and we will not necessarily provide updates of our projections or other forward-looking statements. Investors are cautioned that such forward-looking statements are subject to many risks and uncertainties, and may differ materially or adversely from our actual results or future events. Important risk factors that could have material or adverse effects on our results include practical operational challenges following our recent restructuring and change of business model, the potential loss of key technical and business personnel, uncertainty about the adoption and market acceptance of our technology offerings by current and potential customers and licensees, our inability to predict or ensure that third parties will license our technologies or use our technologies to generate royalties, difficulties in developing our technologies in a timely and cost effective manner, patents and other intellectual property rights, and other risk factors. We urge investors to review our filings with the Securities and Exchange Commission, including our most recent reports on Forms 10-K, 10-Q and 8-K, which describe these and other important risk factors that could have an adverse effect on our results. We undertake no obligation to revise or update publicly any forward-looking statement for any reason.